A critical evaluation of the clinical evidence for pomegranate preparations in the prevention and treatment of cardiovascular diseases

Phytotherapy Research

Volumn 29, Issue 4, 2015, Pages 501-508

  Vlachojannis, Christian ^a   Erne, Paul ^b   Schoenenberger, Andreas W ^c   Chrubasik Hausmann, Sigrun ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Klinik St Anna   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

atherosclerosis; cardiovascular diseases; pomegranate; systematic review

Indexed keywords

MYELOPEROXIDASE; PLACEBO; PLANT EXTRACT;

ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DIETARY INTAKE; ENZYME BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; OUTCOME ASSESSMENT; POMEGRANATE; PREVENTIVE MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; CARDIOVASCULAR DISEASES; CHEMISTRY; LYTHRACEAE;

LYTHRACEAE;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; PLANT EXTRACTS; PUNICACEAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84926473017     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5280     Document Type: Article

References (56)

1. Agosti R, Duke RK, Chrubasik JE, Chrubasik S,. 2006. Effectiveness of Petasites hybridus preparations in the prophylaxis of migraine: a systematic review. Phytomedicine 13: 743-746.
2. Asgary S, Keshvari M, Sahebkar A, Hashemi M, Rafieian-Kopaei M,. 2013. Clinical investigation of the acute effects of pomegranate juice on blood pressure and endothelial function in hypertensive individuals. ARYA Atheroscler 9: 326-331.
3. Asgary S, Sahebkar A, Afshani MR, Keshvari M, Haghjooyjavanmard S, Rafieian-Kopaei M,. 2014. Clinical evaluation of blood pressure lowering, endothelial function improving, hypolipidemic and anti-inflammatory effects of pomegranate juice in hypertensive subjects. Phytother Res 28: 193-199.
4. Aviram M, Dornfeld L, Rosenblat M, et al., 2000. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71: 1062-1076.
5. Aviram M, Dornfeld L,. 2001. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158: 195-198.
6. Aviram M, Rosenblat M, Gaitini D, et al., 2004. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 23: 423-433.
7. Aviram M, Rosenblat M,. 2012. Pomegranate protection against cardiovascular diseases. Evidence-based Complementary and Alternative Medicine 2012: 1-20.
8. Bar M, Roubec M, Farana R, Ličev L, Tomášková H, Školoudík D,. 2014. Inter-rater reliability of carotid atherosclerotic plaque quantification by 3-dimensional sonography. J Ultrasound Med 33 (7): 1273-1278.
9. Basu A, Newman ED, Bryant AL, Lyons TJ, Betts NM,. 2013. Pomegranate polyphenols lower lipid peroxidation in adults with type 2 diabetes but have no effects in healthy volunteers: a pilot study. J Nutr Metab 2013: 708381.
10. Berliner JA, Navab M, Fogelman AM, et al., 1995. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
11. Chrubasik S, Conradt C, Roufogalis BD,. 2004. Effectiveness of Harpagophytum extracts and clinical efficacy. Phytother Res 18: 187-189.
12. Chrubasik C, Duke RK, Chrubasik S,. 2006. The evidence for clinical efficacy of rose hip and seed: a systematic review. Phytother Res 20: 1-3.
13. Chrubasik JE, Roufogalis BD, Wagner H, Chrubasik SA,. 2007a. A comprehensive review on nettle effect and efficacy profiles, part I: herba urticae. Phytomedicine 14: 423-435.
14. Chrubasik JE, Roufogalis BD, Wagner H, Chrubasik S,. 2007b. A comprehensive review on the stinging nettle effect and efficacy profiles, part II: urticae radix. Phytomedicine 14: 568-579.
15. Chrubasik C, Roufogalis BD, Müller-Ladner U, Chrubasik S,. 2008. A systematic review on the Rosa canina effect and efficacy profiles. Phytother Res 22: 725-733.
16. Chrubasik S, Droste C, Black A,. 2009. Asparagus P(R) cannot compete with first-line diuretics in lowering the blood pressure in treatment-requiring antihypertensives. Phytother Res 23: 1345-1346.
17. Chrubasik C, Li G, Chrubasik S,. 2010. The clinical effectiveness of chokeberry: a systematic review. Phytother Res 24: 1107-1114.
18. Chrubasik-Hausmann S, Vlachojannis C, Zimmermann B,. 2014a. Pomegranate juice and prostate cancer: importance of the characterisation of the active principle. Phytother Res Jun 3. Ahead of print 28: 167 6-8.
19. Chrubasik-Hausmann S, Chrubasik C, Walz B, Mönting JS, Erne P,. 2014b. Comparisons of home and daytime ambulatory blood pressure measurements. BMC Cardiovasc Disord 14: 94.
20. Conroy RM, Pyörälä K, Fitzgerald AP, et al., 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24: 987-1003.
21. Davidson MH, Maki KC, Dicklin MR, et al., 2009. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol 104: 936-942.
22. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L,. 2004. Concentrated pomegranate juice improves lipid profiles in diabetic patients with hyperlipidemia. J Med Food 7: 305-308.
23. Esmaillzadeh A, Tahbaz F, Gaieni I, Alavi-Majd H, Azadbakht L,. 2006. Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia. Int J Vitam Nutr Res 76: 147-151.
24. Fenercioglu AK, Saler T, Genc E, Sabuncu H, Altuntas Y,. 2010. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in Type 2 diabetes mellitus without complications. J Endocrinol Invest 33: (1) 18-24.
25. Fuhrman B, Buch S, Vaya J, et al., 1997. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutrc 66: 267-275.
26. Fuhrman B, Rosenblat M, Hayek T, Coleman R, Aviram M,. 2000. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice. J Nutr 130: 1124-1131.
27. Fuhrman B, Volkova N, Coleman R, Aviram M,. 2005. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 135: 722-728.
28. Fuhrman B, Volkova N, Aviram M,. 2010. Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients. Nutrition 26: 359-366.
29. Gagnier JJ, Chrubasik S, Manheimer E,. 2004. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med 4: 13.
30. Habauzit V, Morand C,. 2012. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther Adv Chronic Dis 3: 87-106.
31. Hamoud S, Hayek T, Volkova N, et al., 2014. Pomegranate extract (POMx) decreases the atherogenicity of serum and of human monocyte-derived macrophages (HMDM) in simvastatin-treated hypercholesterolemic patients: a double-blinded, placebo-controlled, randomized, prospective pilot study. Atherosclerosis 232: 204-210.
32. Hashemi M, Kelishadi R, Hashemipour M, et al., 2010. Acute and long-term effects of grape and pomegranate juice consumption on vascular reactivity in paediatric metabolic syndrome. Cardiol Young 20: 73-77. Kelishadi R1, Gidding SS, Hashemi M, Hashemipour M, Zakerameli A
33. Hayek T, Fuhrman B, Vaya J, et al., 1997. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 17: 2744-2752.
34. Heber D, Seeram NP, Wyatt H, et al., 2007. Safety and antioxidant activity of a pomegranate ellagitannin-enriched polyphenol dietary supplement in overweight individuals with increased waist size. J Agric Food Chem 55: 10050-10054.
35. Kelishadi R, Gidding SS, Hashemi M, Hashemipour M, Zakerameli A, Poursafa P,. 2011. Acute and long term effects of grape and pomegranate juice consumption on endothelial dysfunction in pediatric metabolic syndrome. J Res Med Sci 16: 2 45-53.
36. Kolovou G, Anagnostopoulou K, Mikhailidis DP, Cokkinos DV,. 2008. Apolipoprotein E knockout models. Curr Pharm Des 14: 338-351.
37. Konic-Ristic A, Srdic-Rajic T, Kardum N, et al., 2013. Effects of bioactive-rich extracts of pomegranate, persimmon, nettle, dill, kale and Sideritis and isolated bioactives on arachidonic acid induced markers of platelet activation and aggregation. J Sci Food Agric 93: 3581-3587.
38. Loke WM, Proudfoot JM, Hodgson JM, et al., 2010. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 2010 30: 749-757.
39. Lynn A, Hamadeh H, Leung WC, Russell JM, Barker ME,. 2012. Effects of pomegranate juice supplementation on pulse wave velocity and blood pressure in healthy young and middle-aged men and women. Plant Foods Hum Nutr 67: 309-314.
40. Mathew AS, Capel-Williams GM, Berry SE, Hall WL,. 2012. Acute effects of pomegranate extract on postprandial lipaemia, vascular function and blood pressure. Plant Foods Hum Nutr 67: 351-357.
41. Parsaeyan N, Mozaffari-Khosravi H, Mozayan MR,. 2012. Effect of pomegranate juice on paraoxonase enzyme activity in patients with type 2 diabetes. J Diabetes Metab Disord 11: 11.
42. Rock W, Rosenblat M, Miller-Lotan R, Levy AP, Elias M, Aviram M,. 2008. Consumption of wonderful variety pomegranate juice and extract by diabetic patients increases paraoxonase 1 association with high-density lipoprotein and stimulates its catalytic activities. J Agric Food Chem 56: 8704-8713.
43. Rosenblat M, Hayek T, Aviram M,. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages. 2006. Atherosclerosis 187: 363-371.
44. Rosenblat M, Volkova N, Coleman R, Almagor Y, Aviram M,. 2008. Antiatherogenicity of extra virgin olive oil and its enrichment with green tea polyphenols in the atherosclerotic apolipoprotein-E-deficient mice: enhanced macrophage cholesterol efflux. J Nutr Biochem 19: 514-523.
45. Shema-Didi L, Sela S, Ore L, et al., 2012. One year of pomegranate juice intake decreases oxidative stress, inflammation, and incidence of infections in hemodialysis patients: a randomized placebo-controlled trial. Free Radic Biol Med 53: 297-304.
46. Shema-Didi L, Kristal B, Ore L, Shapiro G, Geron R, Sela S,. 2013. Pomegranate juice intake attenuates the increase in oxidative stress induced by intravenous iron during hemodialysis. Nutr Res 2013 33: 442-446.
47. Shema-Didi L, Kristal B, Sela S, Geron R, Ore L,. 2014. Does pomegranate intake attenuate cardiovascular risk factors in hemodialysis patients? Nutr J 13: 18.
48. Stenner-Liewen F, Liewen H, Cathomas R, et al., 2013. Daily pomegranate intake has no impact on PSA levels in patients with advanced prostate cancer-results of a phase IIb randomized controlled trial. J Cancer 4: 597-605.
49. Soare A, Weiss EP, Holloszy JO, Fontana L,. 2013. Multiple dietary supplements do not affect metabolic and cardiovascular health. Aging (Albany NY).
50. Soare A, Weiss EP, Holloszy JO, Fontana L,. 2014. Multiple dietary supplements do not affect metabolic and cardio-vascular health. Aging (Albany NY) 6: 149-157.
51. Sohrab G, Nasrollahzadeh J, Zand H, Amiri Z, Tohidi M, Kimiagar M,. 2014. Effects of pomegranate juice consumption on inflammatory markers in patients with type 2 diabetes: a randomized, placebo-controlled trial. J Res Med Sci 19: 215-220.
52. Sumner MD, Elliott-Eller M, Weidner G, et al., 2005. Effects of pomegranate juice consumption on myocardial perfusion in patients with coronary heart disease. Am J Cardiol 96: 810-814.
53. Vlachojannis JE, Cameron M, Chrubasik S,. 2009. A systematic review on the effectiveness of willow bark for musculoskeletal pain. Phytother Res 23: 897-900.
54. Vlachojannis JE, Cameron M, Chrubasik S,. 2010a. A systematic review on the sambuci fructus effect and efficacy profiles. Phytother Res 24: 1-8.
55. Vlachojannis JE, Cameron M, Chrubasik S,. 2010b. Medicinal use of potato-derived products: a systematic review. Phytother Res 24: 1-8.
56. Warren RE, Marshall T, Padfield PL, Chrubasik S,. 2010. Variability of office, 24-hour ambulatory, and self-monitored blood pressure measurements. Br J Gen Pract 60 (578): 675-680.